Flex Work policy

Corporate Policy

Employee's choice
Employee's choice


Rivus Pharmaceuticals is a pioneering company in mitochondrial biology that focuses on advancing a new class of medicines to combat cardio-metabolic diseases primarily driven by obesity. Their products, known as Controlled Metabolic Accelerators (CMAs), are designed to foster a healthier lifestyle for millions by reducing fat throughout the body and minimizing the risk of cardio-metabolic diseases. Rivus Pharmaceuticals currently conducts clinical studies to prove the efficacy of CMAs.

This content was generated by A.I. Rivus Pharmaceuticals employees can edit to make any changes.